abstract |
The present invention relates to the field of NO synthase inhibition, and more particularly to novel 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing said compounds, and said diseases in diseases characterized by impaired NO levels. It relates to the use of compounds. |